Hogy Medical Co.,Ltd.

3593.T
Medical Instruments & Supplies
2026/02/18 Updated
Market Cap: $940.4M (¥144.5B)
Stock Price: $43.62 (¥6,700)
Exchange Rate: 1 USD = ¥153.61

(Amendment) Notice Regarding Changes to the Expression of Opinion in Support and Recommendation to Apply for the Tender Offer by TCG2509 Co., Ltd. for Shares of the Company

TCG2509 Co., Ltd. has extended the tender offer period for shares of Hogi Medical Co., Ltd. from February 5, 2026, to 40 business days (until February 20, 2026) and changed the settlement start date to March 2, 2026.

Importance:
Page Updated: February 5, 2026
IR Disclosure Date: February 5, 2026

Key Figures

  • Tender Offer Period: From December 18, 2025, to February 20, 2026 (40 business days)
  • Settlement Start Date: Monday, March 2, 2026
  • Number of Shares with Transfer Restrictions: 10,896 shares (ownership ratio 0.05%)

AI要約

Changes to the Tender Offer

On February 4, 2026, TCG2509 Co., Ltd. submitted a notification under the Foreign Exchange and Foreign Trade Act concerning the tender offer aimed at making Hogi Medical Co., Ltd. its wholly owned subsidiary. Along with this, it filed an amendment to the tender offer notification with the Kanto Local Finance Bureau. As a result, the tender offer period was extended from the initial 30 business days to 40 business days, making the period from December 18, 2025, to February 20, 2026. Additionally, the settlement start date was changed from February 13, 2026, to March 2, 2026.

Background and Cautions Regarding the Tender Offer

This tender offer targets the common shares of Hogi Medical Co., Ltd., listed on the Tokyo Stock Exchange Prime Market, aiming to acquire all shares except for treasury stock and shares with transfer restrictions held by directors. The offeror is proceeding with procedures in consultation with related authorities and has implemented measures to ensure fairness and avoid conflicts of interest. Investors are advised to carefully read the tender offer explanatory document and apply at their own discretion. Furthermore, it should be noted that this tender offer is conducted under Japanese law and differs from U.S. securities laws.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.